Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CDH Investments is one of China's largest and most established alternative asset managers, specializing in private equity, venture capital, credit products, real estate, and wealth management. Founded in 2002 and headquartered in Beijing with additional offices across Asia, the firm manages over US$15 billion in assets. It invests across multiple sectors including healthcare and biotechnology but does not itself develop drugs or medical technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CDH Investments.